Cabaletta Bio, Inc. (CABA) income statement
CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.05+0.03 (+3.43%)
Close on Nov 18, 2026Market cap $178.87MP/E –Yield –
Cabaletta Bio, Inc. financial ratios
See a number that looks wrong?